A relevant effect on AKT signaling by lovastatin and simvastatin, respectively, has previously been shown for pheochromocytoma, head and neck squamous cell carcinoma, and T790M mutant NSCLC cell lines [17, 22, 24]. Here, AKT1 is linked to pheochromocytoma.